[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"osteopenia-of-prematurity\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:osteopenia-of-prematurity":51},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":33,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":40,"lastUpdatePostDateStruct":41,"startDateStruct":44,"completionDateStruct":46,"leadSponsor":48,"locationsCount":5},"100531384","the-high-initial-dose-of-monitored-vitamin-d-supplementation-in-preterm-infants-100531384",false,"NCT06199102","The High Initial Dose of Monitored Vitamin D Supplementation in Preterm Infants.","The High Initial Dose of Monitored Vitamin D Supplementation in Preterm Infants. A Randomized Controlled Study.","HIDVID","Inclusion Criteria:\n\n* preterm infants with a gestational age of 24+0\u002F7 to 32+6\u002F7 born at our clinic\n* preterm infants with a gestational age of 24+0\u002F7 to 32+6\u002F7 outborn and admitted to our intensive care unit within 48h after delivery\n* written informed consent form caregivers for the mother and the child to participate in the study\n\nExclusion Criteria:\n\n* infants born at \\>32 weeks of gestation\n* infants with major congenital abnormalities or other severe congenital malformations\n* infants with genetic disorders (diagnosed before and after birth) deemed incompatible with survival\n* infants with diagnosed cholestasis\n* the absence of written informed consent and challenges in communication with caregivers","ALL","1 Day","2 Days",{"count":21,"type":22},130,"ESTIMATED","INTERVENTIONAL",[25],"NA","The aim of this study will be to assess the effectiveness of monitored vit D supplementation in a population of preterm infants and to identify whether the proper vit D supplementation in preterm infants can reduce the incidence of neonatal sepsis and incidence of metabolic bone disease.",[28,29,30,31,32],"Vitamin D Deficiency","Osteopenia of Prematurity","Nephrolithiasis","Metabolic Bone Disease","Late-Onset Neonatal Sepsis",[34,35,36,37,38],"vitamin D","preterm infants","osteopenia of prematurity","late-onset sepsis","metabolic bone disease","NOT_YET_RECRUITING","2024-01-09",{"date":42,"type":43},"2024-01-10","ACTUAL",{"date":45,"type":22},"2024-09-01",{"date":47,"type":22},"2027-12-31",{"name":49,"class":50},"Princess Anna Mazowiecka Hospital, Warsaw, Poland","OTHER","Osteopenia Of Prematurity"]